Covid-19: WHO makes u-turn on Chloroquine trial
GENEVA – The World Health Organization (WHO) has made a u-turn and is resuming hydrochloroquine trial for treatment of COVID-19 patients.
Last week, WHO Director-General, Tedros Ghebreyesus, announced a “temporary pause” in the solidarity trial of the drug.
However, speaking during a virtual press conference on Wednesday, Tedros said the drug trial will now commence.
According to him, findings by the health agency’s data safety monitoring board, showed that there was no reason to discontinue the trial.
Tedros said the executive group endorsed the recommendation, adding that “all arms of the solidarity trial” will continue.
“The executive group received this recommendation and endorsed continuation of all arms of the solidarity trial, including hydroxychloroquine.
“The executive group will communicate with the principal investigators in the trial about resuming the hydroxychloroquine arm of the trial.
“The data safety and monitoring committee will continue to closely monitor the safety of all therapeutics being tested in the solidarity trial,” he added.
- Zest World Ent. boss Soulnize Anya celebrates birthday with a new song [Check out]
- BREAKING: Polytechnics shut down as ASUP begins indefinite strike
- 2021 UTME: Jamb set to commence sell of forms
- UAM Students Union Week 2021(All You Need To Know About The Event)
- Susan Ngusha Zapaseve, Kumashe U Tiv International 2020 and her Pet Project